Figure 5

From: Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum

Figure 5

Diffuse cytoplasmic expression of glypican-3 in fibrolamellar hepatocellular carcinoma (× 200).